Clinical Trial Detail

NCT ID NCT02563925
Title Brain Irradiation and Tremelimumab in Metastatic Breast Cancer
Recruitment Active, not recruiting
Gender female
Phase Phase I
Variant Requirements No
Sponsors Memorial Sloan Kettering Cancer Center
Indications

breast cancer

Therapies

Tremelimumab

Age Groups: adult

No variant requirements are available.